The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.

Congress advances legislation to expand Medicare coverage for multi-cancer early detection tests, aiming to save lives through innovative screenings and improved access for seniors nationwide.

More young adults are also being diagnosed, according to Yale Medicine and the Cancer Research Institute. According to the ...

U.S. Senators Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) today introduced the Non-Opioids Prevent Addiction ...

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...

Patients who take omalizumab prior to starting oral immunotherapy (OIT) may skip much of the latter treatment’s onerous dose ...

Knowable Magazine reports on a new blood test, myLuma, predicting postpartum depression risk with over 80% accuracy, aiding ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

J&J (JNJ) stock and Halozyme Therapeutics (HALO) stock are in focus as their multiple myeloma therapy Darzalex Faspro is granted traditional FDA nod. Read more here.

The U.S. Food and Drug Administration on Wednesday approved Bayer's drug for patients with a type of lung cancer. The drug, ...